BiotechTube
Home/Empros Pharma/Mark Quick
MQ

Mark Quick

Business Developer

Empros Pharma

Therapeutic Areas

ObesityMetabolic Disease

Empros Pharma Pipeline

DrugIndicationPhase
EMP16Weight-loss maintenance in obesityPhase 2

Leadership Team at Empros Pharma

AS
Arvid Söderhäll
Chief Executive Officer
UH
Ulf Holmbäck
Chief Scientific Officer, Co-founder
SG
Stefan Grudén
Chief Technology Officer & Head of Quality Assurance
HS
Halide Shala
Controller
View full Empros Pharma profile